A

Arrowhead Pharmaceuticals
D

ARWR

19.450
USD
-0.02
(-0.10%)
Market Closed
Volume
49,534
EPS
-3
Div Yield
-
P/E
-4
Market Cap
2,420,249,897
OverviewSignalsIdeasNews
Related Instruments
    ALNY
    ALNY
    6.675
    (2.79%)
    245.505 USD
    C
    CRSP
    0.360
    (0.89%)
    40.720 USD
    E
    EDIT
    -0.01000
    (-0.75%)
    1.32000 USD
    MRNA
    MRNA
    -0.200
    (-0.51%)
    39.360 USD
    N
    NTLA
    0.120
    (0.99%)
    12.190 USD
    REGN
    REGN
    -5.64
    (-0.80%)
    702.60 USD
    S
    SLDB
    0.14500
    (3.62%)
    4.15000 USD
    V
    VYGR
    0.06000
    (1.05%)
    5.76000 USD
    More
News

Title: Arrowhead Pharmaceuticals

Sector: Healthcare
Industry: Biotechnology
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.